Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

por Bouwer, Nathalie I., Jager, Agnes, Liesting, Crista, Kofflard, Marcel J.M., Brugts, Jasper J., Kitzen, Jos J.E.M., Boersma, Eric, Levin, Mark-David
Publicado 2020

2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab

por Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Brugts, Jasper J., Kock, Marc C. J., Kitzen, Jos J. E. M., Levin, Mark-David, Boersma, Eric
Publicado 2021

Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with Cancer

por Rier, Hánah N, Meinardi, Marieke C, van Rosmalen, Joost, Westerweel, Peter E, de Jongh, Eva, Kitzen, Jos J E M, van den Bosch, Joan, Trajkovic, Marija, Levin, Mark-David
Publicado 2022

NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab

por Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Sprangers-van Campen, Sylvia M., Brugts, Jasper J., Kitzen, Jos J. E. M., Fouraux, Michael A., Levin, Mark-David, Boersma, Eric
Publicado 2019

Effectiveness of a Hospital-Based Work Support Intervention for Female Cancer Patients – A Multi-Centre Randomised Controlled Trial

por Tamminga, Sietske J., Verbeek, Jos H. A. M., Bos, Monique M. E. M., Fons, Guus, Kitzen, Jos J. E. M., Plaisier, Peter W., Frings-Dresen, Monique H. W., de Boer, Angela G. E. M.
Publicado 2013

The effect of trastuzumab on cardiac function in patients with HER2‐positive metastatic breast cancer and reduced baseline left ventricular ejection fraction

por Bouwer, Nathalie I., Steenbruggen, Tessa G., Rier, Hánah N., Kitzen, Jos J. E. M., Smorenburg, Carolien H., van Bekkum, Marlies L., de Jong, Paul C., Drooger, Jan C., Holterhues, Cynthia, Kofflard, Marcel J. M., Boersma, Eric, Sonke, Gabe S., Levin, Mark‐David, Jager, Agnes
Publicado 2022